Key result
The EERIAM-HCC risk stratification scale accurately predicted intrahospital death in patients with ST-segment elevation myocardial infarction, achieving a detectability index of 0.92.
Why the study?
Existing risk prediction scales for acute coronary syndrome rely on angiographic studies and serum biomarkers that are inaccessible in resource-limited settings.
Does the EERIAM-HCC risk scale accurately predict intrahospital death in patients with STEMI?
Observational (n=667)
No
Does the EERIAM-HCC risk scale accurately predict intrahospital death in patients with STEMI?
Effect estimate: detectability index 0.92
The EERIAM-HCC scale provides a highly predictive, accessible tool for stratifying the risk of intrahospital death in STEMI patients in resource-limited settings without access to angiography or serum biomarkers.
New accessible STEMI mortality risk scale shows strong predictive ability; leaves open external validation and clinical utility before adoption.
INTRODUCTION The scales available to predict death and complica-tions after acute coronary syndrome include angiographic studies and serum biomarkers that are not within reach of services with limited resources. Such services need specifi c and sensitive instruments to evaluate risk using accessible resources and information. OBJECTIVE Develop a scale to estimate and stratify the risk of intra-hospital death in patients with acute ST-segment elevation myocardial infarction. METHODS An analytical observational study was conducted in a universe of 769 patients with acute ST-segment elevation myocardial infarction who were admitted consecutively to the Camilo Cienfuegos Provincial Hospital in Sancti Spíritus Province, Cuba, from January 2013 to March 2018. The fi nal study cohort included 667 patients, ex-cluding 102 due to branch blocks, atrial fi brillation, drugs that prolong the QT interval, low life expectancy or history of myocardial infarction. The demographic variables of age, sex, skin color, classic cardiovas-cular risk factors, blood pressure, heart rate, blood glucose level, in addition to duration and dispersion of the QT interval with and without correction, left ventricular ejection fraction, and glomerular fi ltration rate were included in the analysis. Patients were categorized according to the Killip-Kimball Classifi cation for degree of heart failure. A risk scale was constructed, the predictive ability of which was evaluated using the detectability index associated with an receiver-operator curve.RESULTS Seventy-seven patients died (11.5%). Mean blood glucose levels were higher among the deceased, while their systolic and dia-stolic blood pressure, left ventricular ejection fraction, and glomerular fi ltration rate were lower than those participants discharged alive. Rel-evant variables included in the scale were systolic blood pressure, Killip-Kimball class, cardiorespiratory arrest, glomerular fi ltration rate, corrected QT interval dispersion, left ventricular ejection fraction, and blood glucose levels. The variable with the best predictive ability was cardiorespiratory arrest, followed by a blood glucose level higher than 11.1 mmol/L. The scale demonstrated a great predictive ability with a detectability index of 0.92. CONCLUSIONS The numeric scale we designed estimates and strati-fi es risk of death during hospitalization for patients with ST-segment elevation myocardial infarction and has good metric properties for predictive ability and calibration. KEYWORDS ST-segment elevation myocardial infarction, mortality, risk assessment, Cuba.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Jiménez et al. (2020) conducted an observational in Acute ST-segment elevation myocardial infarction (n=667). EERIAM-HCC risk stratification scale was evaluated on Intrahospital death (detectability index 0.92). The EERIAM-HCC risk stratification scale accurately predicted intrahospital death in patients with ST-segment elevation myocardial infarction, achieving a detectability index of 0.92.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: